• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tenoxicam: acute dose-dependent disposition studies in rats.

作者信息

Lopez-Bustamante L G, Troconiz J I, Fos D

机构信息

Dpto. Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Navarra, Pamplona, Spain.

出版信息

J Pharm Sci. 1993 Aug;82(8):851-3. doi: 10.1002/jps.2600820820.

DOI:10.1002/jps.2600820820
PMID:8377127
Abstract

Single intravenous bolus doses of tenoxicam of 2.5, 5, and 10 mg/kg were administered to male Wistar rats to determine the effects of dose on tenoxicam pharmacokinetics. Predicted apparent volume of distribution at steady state (Vdss) and total plasma clearance (CL) were, respectively, 42 and 45% higher in the animals given 10-mg/kg dose than the animals given 2.5- and 5-mg/kg doses. Binding of tenoxicam to plasma proteins showed saturability, with a 33% higher unbound fraction of tenoxicam in plasma when total drug concentration in plasma was 36 mg/L (high dose group) in comparison with animals given the low doses (12 and 20 mg/L). The blood-to-plasma concentration ratio of tenoxicam was concentration independent and therefore did not account for the observed dose-dependent changes in Vdss and CL.

摘要

相似文献

1
Tenoxicam: acute dose-dependent disposition studies in rats.
J Pharm Sci. 1993 Aug;82(8):851-3. doi: 10.1002/jps.2600820820.
2
Intranasal delivery of tenoxicam in rat.大鼠鼻内给予替诺昔康
Int J Pharm. 2001 Jun 19;221(1-2):227-9. doi: 10.1016/s0378-5173(01)00635-4.
3
Effect of uraemia and anephric state on the pharmacokinetics of tenoxicam in the rat.
J Pharm Pharmacol. 1992 Nov;44(11):898-901. doi: 10.1111/j.2042-7158.1992.tb03232.x.
4
Plasma tenoxicam concentrations after single and multiple oral doses.
Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):23-7. doi: 10.1007/BF03190838.
5
Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.替诺昔康在肾功能受损患者和健康志愿者中的单剂量及多剂量药代动力学、肾脏耐受性和血浆蛋白结合情况。
Pharmacol Toxicol. 2001 Nov;89(5):265-72. doi: 10.1034/j.1600-0773.2001.d01-158.x.
6
Tenoxicam pharmacokinetics in rats: a population model.替诺昔康在大鼠体内的药代动力学:群体模型
J Pharm Sci. 1995 Dec;84(12):1482-7. doi: 10.1002/jps.2600841216.
7
Single and multiple dose pharmacokinetics of tenoxicam in the elderly.替诺昔康在老年人中的单剂量和多剂量药代动力学
Eur J Clin Pharmacol. 1988;35(5):563-6. doi: 10.1007/BF00558254.
8
Pharmacokinetics of tenoxicam in healthy human volunteers.
Eur J Rheumatol Inflamm. 1984;7(2):33-44.
9
High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.血浆、血液及缓冲溶液中吡罗昔康和替诺昔康的高效液相色谱分析。在小型实验动物药代动力学研究中的应用。
Arzneimittelforschung. 1993 Jun;43(6):679-81.
10
Pharmacokinetics of tenoxicam at different dosage regimes.
Farmaco. 1993 Sep;48(9):1321-5.